Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology Scientific and Clinical Aspects of Anemia in Cancer /
Anemia is a frequent complication of cancer and its treatment. It produces many symptoms and significantly impairs metabolic and physiologic functions as well as patients' activity, well-being and quality of life. Life expectancy is also affected. This book, now being published in its second ed...
| Συγγραφή απο Οργανισμό/Αρχή: | |
|---|---|
| Άλλοι συγγραφείς: | |
| Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
Vienna :
Springer Vienna,
2008.
|
| Έκδοση: | Second, Revised and Enlarged Edition. |
| Θέματα: | |
| Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Physiology of erythropoiesis
- Biology of EPO and EPO-receptor
- The role of erythropoietin receptor expression on tumor cells
- Problems associated with erythropoietin receptor determination on tumor cells
- Definition, classification and characterization of anemia in cancer
- Pathophysiology of anemia in cancer
- Prevalence and incidence of anemia and risk factors for anemia in patients with cancer
- Significance of anemia in cancer chemotherapy
- Incidence and impact of anemia in radiation oncology
- Relationship between hemoglobin levels and tumor oxygenation
- Tumor hypoxia and therapeutic resistance
- Symptoms of anemia
- Impact of anemia and red blood cell transfusion on organ function
- Relationship of hemoglobin, fatigue, and quality of life in anemic cancer patients
- When to use red blood cell transfusions in cancer patients with solid tumours?
- Pharmacology, pharmacokinetics and safety of recombinant human erythropoietin preparations
- Epoetin treatment of anemia associated with multiple myeloma and non-Hodgkin’s lymphoma
- rhEPO in anemic patients with solid tumors and chemotherapy — efficacy and safety
- Early intervention with recombinant human erythropoietin for chemotherapy-induced anemia
- Recombinant human erythropoietin (rhEPO) therapy in myelodysplasia
- Prediction of response to rhEPO in the anemia of cancer
- rhEPO in hematopoietic stem cell transplantation
- Treatment of anemia with rhEPO in radiation oncology
- Recombinant human erythropoietin in pediatric oncology
- rhEPO in surgical oncology
- Erythropoiesis, iron metabolism and iron supplementation during erythropoietin therapy
- Are there risks for use of iron in cancer patients?
- Metabolic and physiologic effects of rhEPO in anemic cancer patients
- Effects of rhEPO on quality of life in anemic cancer patients
- Thrombosis during therapy with erythropoiesis stimulating agents in cancer
- The effect of rhEPO on survival in anemic cancer patients
- From bench to bedside: Neuroprotective effects of erythropoietin
- rhEPO in patients with anemia and congestive heart failure
- Cost-effectiveness of treating cancer anaemia.
